AKR1C3 and polycystic ovary syndrome: Third, and notably, elevated expression and activity of AKR1C3 in AT of PCOS patients—this enzyme converts androstenedione to testosterone—creates a local insulin-androgen activation feedback loop that amplifies androgen production within AT itself (59, 60).